BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/22/2022 12:23:56 PM | Browse: 368 | Download: 1562
 |
Received |
|
2022-03-03 07:55 |
|
Peer-Review Started |
|
2022-03-03 07:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-19 06:55 |
|
Revised |
|
2022-04-28 12:10 |
|
Second Decision |
|
2022-08-24 03:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-08-26 17:55 |
|
Articles in Press |
|
2022-08-26 17:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-08-16 13:17 |
|
Typeset the Manuscript |
|
2022-09-16 08:05 |
|
Publish the Manuscript Online |
|
2022-09-22 12:23 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Liu, Feng-Lin Chen, Kun Wang, Quan Bao, Hong-Wei Wang, Ke-Min Jin and Bao-Cai Xing |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Nature Science Foundation of China |
81874143, 31971192 |
| Beijing Hospitals Authority Youth Program |
QMS20201105 |
|
| Corresponding Author |
Bao-Cai Xing, N/A, N/A, N/A, Department of Hepatopancreatobiliary Surgery, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. xingbaocai88@sina.com |
| Key Words |
Colorectal cancer; Liver metastasis; Liver resection; Neoadjuvant chemotherapy |
| Core Tip |
This was the first retrospective cohort study to investigate irinotecan-based regimens for neoadjuvant chemotherapy in patients with colorectal liver metastasis (CRLM) in China. It highlighted the benefits of irinotecan and might contribute to modifying the treatment guidelines for CRLM. Chemotherapy was based on oxaliplatin in 353 (63.7%) patients and irinotecan in 201 (36.3%). After propensity score matching, the 5-year progression-free survival (PFS) and overall survival (OS) rates with irinotecan were 18.0% and 49.7%, respectively, while the 5-year PFS and OS rates with oxaliplatin were 26.0% and 46.8%, respectively. |
| Publish Date |
2022-09-22 12:23 |
| Citation |
Liu W, Chen FL, Wang K, Bao Q, Wang HW, Jin KM, Xing BC. Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study. World J Gastrointest Surg 2022; 14(9): 904-917 |
| URL |
https://www.wjgnet.com/1948-9366/full/v14/i9/904.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v14.i9.904 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
